Thomas, G., Frederick, E., Hausburg, M., Goldberg, L., Hoke, M., Roshon, M., . . . Bar-Or, D. (2020). The novel immunomodulatory biologic LMWF5A for pharmacological attenuation of the “cytokine storm” in COVID-19 patients: A hypothesis. Patient Saf Surg.

Thomas, Gregory, Elizabeth Frederick, Melissa Hausburg, Laura Goldberg, Marshall Hoke, Michael Roshon, Charles Mains, a David Bar-Or. "The Novel Immunomodulatory Biologic LMWF5A for Pharmacological Attenuation of the “cytokine Storm” in COVID-19 Patients: A Hypothesis." Patient Saf Surg 2020.

Thomas, Gregory, et al. "The Novel Immunomodulatory Biologic LMWF5A for Pharmacological Attenuation of the “cytokine Storm” in COVID-19 Patients: A Hypothesis." Patient Saf Surg 2020.